Sepsis Market Forecast: What to Expect by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Sepsis Market Between 2025 And 2029?

The sepsis market has experienced robust expansion recently. Projections indicate it will expand from $0.93 billion in 2024 to $1.02 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.0%. Historically, this growth has been driven by factors such as a greater incidence of sepsis stemming from aging populations, an increase in chronic disease prevalence, enhanced awareness of sepsis among medical professionals, rising healthcare spending, and governmental efforts focused on early diagnosis and treatment.

The sepsis market is projected for robust expansion over the coming years, with its size expected to reach $1.43 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.8%. This growth during the forecast period is primarily attributed to the increasing integration of artificial intelligence in critical care, the escalating prevalence of multidrug-resistant infections, expanding awareness campaigns dedicated to sepsis, the continuous development of healthcare infrastructure in emerging economies, and increased investments in biotechnology and pharmaceutical research. Furthermore, significant trends anticipated in the forecast period include the advancement of rapid point-of-care diagnostics, the wider adoption of AI-driven predictive analytics, the implementation of personalized antibiotic stewardship programs, notable improvements in blood culture techniques, the identification of innovative biomarkers, and the development of novel therapies focused on immune modulation.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21286&type=smp

Which Drivers Are Supporting Growth Of The Sepsis Market?

The sepsis market is projected to expand due to the rising prevalence of infectious diseases. These diseases are health conditions resulting from the invasion of the body by bacteria, viruses, fungi, or parasites. Examples of such common illnesses are tuberculosis, influenza, ringworm, and malaria, which can be transmitted via direct contact, tainted sources, or insect carriers. The occurrence of infectious diseases is influenced by population growth, global interconnectedness, shifts in the environment, the emergence of drug-resistant pathogens, and deficiencies within healthcare infrastructures. Sepsis, a serious complication of infections, develops when the body exhibits an overwhelming reaction to them, resulting in systemic inflammation and possible organ dysfunction. For instance, in November 2024, according to the Centers for Disease Control and Prevention, a US-based government agency for public health, in 2023, the United States recorded 9,633 cases of tuberculosis(TB), marking a 15.6% rise from 8,332 cases reported in 2022. Consequently, the growing prevalence of infectious diseases is propelling the expansion of the sepsis market.

How Is The Sepsis Market Classified Into Different Segments?

The sepsismarket covered in this report is segmented –

1) By Type: Diagnosis; Therapeutics

2) By Pathogen: Bacterial; Viral; Fungal

3) By Application: Severe Sepsis; Septic Shock

4) By End User: Hospitals; Pathology; Reference Laboratories

Subsegments:

1) By Diagnosis: Blood Tests; Imaging Techniques; Microbiological Culture Tests; Biomarker Tests; Other Diagnostic Methods

2) By Therapeutics: Antibiotics; Antifungal Agents; Vasopressors; Immunoglobulins; Corticosteroids; Other Therapeutic Options

Which Trends Are Impacting The Sepsis Market?

Companies operating within the sepsis market are concentrating on developing advanced technological platforms, such as those leveraging artificial intelligence (AI), to improve prompt diagnosis, increase treatment accuracy, and predict patient outcomes. The overarching aim is to decrease mortality rates and boost healthcare efficiency in managing sepsis. For example, in June 2024, Predicate Healthcare Performance Group (HPG), a US-based healthcare company, launched its AI software platform, OpenDX. This innovative platform combines AI-powered diagnostics with wearable biosensors, enabling healthcare providers to detect early signs of sepsis. This development aids in sepsis diagnosis and possesses the potential to extend its application to other health conditions, thereby highlighting technology’s critical role in diagnostics. Predicate’s chest sensor helps healthcare workers identify early sepsis signs, a diagnosis that is both challenging and often missed.

Who Are The Primary Competitors In The Global Sepsis Market?

Major companies operating in the sepsis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck KGaA, Bayer AG, Thermo Fisher Scientific Inc., Abbott laboratories, Novartis AG, Siemens AG, Asahi Kasei Corporation, Becton, Dickinson and Company, bioMérieux SA, QuidelOrtho Corporation, Diasorin S.p.A., Innoviva Inc., Seegene Inc., EKF Diagnostics, Boditech Med Inc., Cytovale Inc., Alifax S.r.l., Hansa Biopharma, Amomed Pharma GmbH, Inotrem S.A., Abionic SA, Biosystems Inc., Immunexpress Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/sepsis-global-market-report

What Are The Regional Market Dynamics Impacting The Sepsis Industry?

North America was the largest region in the sepsis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sepsis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Sepsis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21286&type=smp

Browse Through More Reports Similar to the Global Sepsis Market 2025, By The Business Research Company

Lateral Flow Immunoassay Based Rapid Test Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

Cellulars Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

Immuno Oncology Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795